dc.creator | Ridruejo, Ezequiel | |
dc.creator | Soza, Alejandro M. D. | |
dc.date.accessioned | 2021-02-25T18:11:57Z | |
dc.date.accessioned | 2022-10-15T03:19:02Z | |
dc.date.available | 2021-02-25T18:11:57Z | |
dc.date.available | 2022-10-15T03:19:02Z | |
dc.date.created | 2021-02-25T18:11:57Z | |
dc.date.issued | 2019-03-04 | |
dc.identifier | Ridruejo, Ezequiel; Soza, Alejandro M. D.; Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?; John Wiley & Sons Inc; Clinical Liver Disease; 13; 2; 4-3-2019; 43-45 | |
dc.identifier | 2046-2484 | |
dc.identifier | http://hdl.handle.net/11336/126656 | |
dc.identifier | CONICET Digital | |
dc.identifier | CONICET | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4339330 | |
dc.description.abstract | Hepatitis C virus (HCV) infection is a global health concern with an estimated worldwide disease prevalence rate of 1%, meaning 71 million individuals are infected.1 In the United States, the estimated prevalence rate is 0.7%, or 7 million individuals.1 Specifically in Latin America, estimations suggest that only 25% of individuals with suspected HCV infection have been diagnosed, and only 4% received treatment.2 Recent availability in this region of directacting antivirals (DAAs), which are safer and more effective than the interferon-based therapies, may influence treatment paradigms at country levels. | |
dc.language | eng | |
dc.publisher | John Wiley & Sons Inc | |
dc.relation | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/cld.771 | |
dc.relation | info:eu-repo/semantics/altIdentifier/url/https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/cld.771 | |
dc.rights | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | HEPATITIS C | |
dc.subject | ERRADICATION | |
dc.subject | LATIN AMERICA | |
dc.subject | TREATMENT | |
dc.title | Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030? | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:ar-repo/semantics/artículo | |
dc.type | info:eu-repo/semantics/publishedVersion | |